Overview
What is National Alliance For Model State Drug Laws?
The National Alliance for Model State Drug Laws (NAMSDL) serves as a valuable resource for various stakeholders, including governors, legislators, attorneys general, local prosecutors, drug and alcohol specialists, health professionals, community leaders, and the recovering community. Its primary role is to provide them with comprehensive information and guidance on crafting effective drug laws at the state level. NAMSDL aims to enhance public safety and promote substance abuse prevention and treatment efforts through its mission.
Official website here: www.namsdl.com
Is National Alliance For Model State Drug Laws legitimate?
National Alliance For Model State Drug Laws is a legitimate nonprofit organization registered as a 501(c)(3) entity. National Alliance For Model State Drug Laws submitted a form 990EZ, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Official website here: www.namsdl.com
What is the mission statement of National Alliance For Model State Drug Laws?
The National Alliance for Model State Drug Laws (NAMSDL) serves as a valuable resource for various stakeholders, including governors, state legislators, attorneys general, local prosecutors, drug and alcohol professionals, health professionals, community leaders, and the recovering community. Its mission, in essence, is to provide them with the necessary tools and knowledge to effectively address drug-related issues at the state level. NAMSDL does not have a specific mission statement per se, but its role can be interpreted as advocating for evidence-based drug laws and policies that promote public health and safety. It aims to support these stakeholders in their efforts to combat substance abuse and promote recovery, ultimately contributing to safer and healthier communities.
Official website here: www.namsdl.com
Who is the CEO of National Alliance For Model State Drug Laws?
Michele Worobiec is the President of National Alliance For Model State Drug Laws.
Official website here: www.namsdl.com
What is the revenue of National Alliance For Model State Drug Laws?
National Alliance For Model State Drug Laws's revenue in 2022 was $29,084.
Official website here: www.namsdl.com
Who are the executives of National Alliance For Model State Drug Laws and what are their salaries?
Here are 12 key members and their salaries:
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
Official website here: www.namsdl.com
Where can I find the form 990EZ for National Alliance For Model State Drug Laws?
National Alliance For Model State Drug Laws's most recent form 990EZ was submitted in 2022 and can be accessed here.
Official website here: www.namsdl.com
Learn more at the official website: www.namsdl.com
Mission Statement of National Alliance For Model State Drug Laws
The National Alliance for Model State Drug Laws, abbreviated as NAMSDL, serves as a valuable resource for various stakeholders in the fight against substance abuse. This nonprofit organization aims to support governors, state legislators, attorneys general, local prosecutors, drug and alcohol professionals, health professionals, community leaders, and the recovering community. By providing them with essential resources, NAMSDL seeks to influence the development of effective drug laws at the state level. This mission is crucial in the broader effort to tackle substance abuse issues and promote recovery. The organization's role is instrumental in ensuring that drug laws are evidence-based, balanced, and responsive to the evolving challenges in the field.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
August, 2024
The National Alliance for Model State Drug Laws (NAMSDL) plays a crucial role in providing resources and guidance to governors, state legislators, attorneys general, local prosecutors, drug and alcohol professionals, health professionals, community leaders, and the recovering community. NAMSDL's impact can be seen in its efforts to shape drug policy at the state level, providing valuable information and recommendations to improve drug laws and regulations. Through its work, NAMSDL contributes to the development of effective and evidence-based strategies to address drug-related issues, ultimately aiming to create healthier and safer communities across the country.
This information is meant to be a general summary of National Alliance For Model State Drug Laws. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Gross Receipts: $29,084
Assets and Liabilities:
- Total Assets: $2,565
- Total Liabilities: $0
- Net Assets: $2,565
Want to help this charity, for free? You can click here to learn more about Give Freely
Organization Details
Phone
(703) 836-6100Principal Officer
Michele Worobiec
Main Address
715 Shawan Falls Drive 1102, Dublin, OH, 43017
Website
www.namsdl.comNTEE Category
Code: T60Z - Philanthropy
If you are a representative of National Alliance For Model State Drug Laws and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.